| Name | long intergenic non-protein coding RNA 693 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Recent transcriptome studies have increasingly implicated long non‐coding RNAs (lncRNAs) in neurodevelopmental disorders such as autism spectrum disorder (ASD). In particular, analyses of ASD brain tissue have revealed a dysregulated noncoding RNA landscape, with several lncRNAs exhibiting altered expression levels that may impact neuronal differentiation, synaptic regulation, and key signaling pathways."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Among these, LINC00693 has been reported to be significantly overexpressed in ASD cases relative to controls, distinguishing its profile from other lncRNAs that are downregulated in the disorder."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Although its precise mechanistic role remains to be fully elucidated, the aberrant expression of LINC00693 suggests that it could contribute to the deregulation of gene networks and signaling cascades—such as those mediated via the PI3K/Akt/mTOR and EGFR pathways—that are thought to underlie ASD pathobiology. While studies focusing on epigenetic landscapes in other disease contexts (for example, the proto-CpG island methylator phenotype in colon precancers;"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "have not specifically addressed LINC00693, the collective findings across these reports highlight the broader relevance of lncRNA dysregulation in human disease and underscore the potential utility of LINC00693 as a biomarker or therapeutic target in ASD.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Neelroop N Parikshak, Vivek Swarup, T Grant Belgard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature20612"}], "href": "https://doi.org/10.1038/nature20612"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27919067"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27919067"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jun-Hua Nie, Tian-Xiang Li, Xiao-Qin Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Roles of Non-Coding RNAs in Normal Human Brain Development, Brain Tumor, and Neuropsychiatric Disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Noncoding RNA (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ncrna5020036"}], "href": "https://doi.org/10.3390/ncrna5020036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31052326"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31052326"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Soudeh Ghafouri-Fard, Rezvan Noroozi, Serge Brand, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Emerging Role of Non-coding RNAs in Autism Spectrum Disorder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Neurosci (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12031-021-01934-3"}], "href": "https://doi.org/10.1007/s12031-021-01934-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34767189"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34767189"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hannah R Parker, Stephany Orjuela, Andreia Martinho Oliveira, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The proto CpG island methylator phenotype of sessile serrated adenomas/polyps."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epigenetics (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15592294.2018.1543504"}], "href": "https://doi.org/10.1080/15592294.2018.1543504"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30398409"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30398409"}]}]}]}
|
| NCBI Gene ID | 645206 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
LINC00693 has 629 functional associations with biological entities spanning 4 categories (disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 12 datasets.
Click the + buttons to view associations for LINC00693 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00693 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00693 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of LINC00693 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of LINC00693 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of LINC00693 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of LINC00693 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with LINC00693 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with LINC00693 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00693 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain LINC00693 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of LINC00693 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of LINC00693 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |